Rapid and Long-Acting Analogues as an Approach to Improve Insulin Therapy: An Evidence-Based Medicine Assessment

E-ISSN： 1873-4286|7|14|1303-1325

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.14, 2001-09, pp. : 1303-1325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin Aspart: An Evidence-Based Medicine Review

By Alan Haycox

Clinical Drug Investigation, Vol. 24, Iss. 12, 2004-01 ,pp. : 695-717

Adis International

Access to resources Recommend Favorite

Rapid Acting Insulinotropic Agents: Restoration of Early Insulin Secretion as a Physiologic Approach to Improve Glucose Control

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1375-1397

Bentham Science Publishers

Access to resources Recommend Favorite

Choice of Long-Acting Insulin Therapy for Type 2 Diabetes: How Can Treatment for Older People be Optimized?

By Krentz Andrew J. Sinclair Alan J.

Drugs & Aging, Vol. 28, Iss. 12, 2011-12 ,pp. : 935-941

Adis International

Access to resources Recommend Favorite

Guidelines for monitoring of methotrexate therapy: “Evidence‐based medicine” outside of clinical trials

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2706-2709

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stability of Two Long‐Acting Insulin Formulations after 28 Days

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 43, Iss. 1, 2013-03 ,pp. : 37-40

John Wiley & Sons Inc

Access to resources Recommend Favorite